Long-term treatment of psoriasis with cyclosporin A--side-effects, minimal effective dose and cyclosporin blood levels. 1991

M J Korstanje, and W J Van de Staak
Department of Dermatology, Academic Hospital Maastricht, The Netherlands.

Fourteen patients with psoriasis received long-term treatment with cyclosporin (CsA). Among patients there was great variability in the minimal effective CsA dose. In most patients long-term treatment was limited due to dose reductions made necessary because of side-effects. The therapeutic window for CsA seems small. CsA blood levels associated with side-effects and with the minimal effective dose are in the same range and correlation between CsA blood levels and effectiveness in psoriasis is weak. Therefore, in CsA therapy for psoriasis, without concomitant medication which may influence CsA blood levels, the measurement of CsA blood levels is not necessarily helpful in optimizing therapy or preventing side-effects.

UI MeSH Term Description Entries
D008134 Long-Term Care Care over an extended period, usually for a chronic condition or disability, requiring periodic, intermittent, or continuous care. Care, Long-Term,Long Term Care
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011565 Psoriasis A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis. Palmoplantaris Pustulosis,Pustular Psoriasis of Palms and Soles,Pustulosis Palmaris et Plantaris,Pustulosis of Palms and Soles,Psoriases
D003524 Cyclosporins A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. Cyclosporines
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

M J Korstanje, and W J Van de Staak
April 1992, Journal of autoimmunity,
M J Korstanje, and W J Van de Staak
March 2002, Clinical and experimental dermatology,
M J Korstanje, and W J Van de Staak
May 1990, The British journal of dermatology,
M J Korstanje, and W J Van de Staak
January 1989, Acta dermato-venereologica. Supplementum,
M J Korstanje, and W J Van de Staak
February 1989, The British journal of dermatology,
M J Korstanje, and W J Van de Staak
February 2000, Annales de dermatologie et de venereologie,
M J Korstanje, and W J Van de Staak
September 1990, The British journal of dermatology,
M J Korstanje, and W J Van de Staak
January 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
M J Korstanje, and W J Van de Staak
August 1994, Pediatric nephrology (Berlin, Germany),
M J Korstanje, and W J Van de Staak
April 1997, The British journal of dermatology,
Copied contents to your clipboard!